Quantitative Structure Activity Relationship Studies of Potent Endothelin-A Receptor Antagonist for the Treatment of Pulmonary Arterial Hypertension. IJC 2024, 63 (2), 190-202. https://doi.org/10.56042/ijc.v63i2.6141.